NVS: Novartis AG Stocks News on June 1, 2025

Buy These 5 Low-Leverage Stocks Amid Volatile Market Sentiment

NVS

Zacks

2 days ago

Buy These 5 Low-Leverage Stocks Amid Volatile Market Sentiment

What Makes Novartis AG (NVS) a Differentiated Business?

NVS

Insider Monkey

5 days ago

What Makes Novartis AG (NVS) a Differentiated Business?

Novartis announces commencement of tender offer to acquire Regulus Therapeutics

NVS

GlobeNewswire

5 days ago

Novartis announces commencement of tender offer to acquire Regulus Therapeutics

NVS

MT Newswires

10 days ago

Market Chatter: Court Denies Novartis' Motion to Dismiss Lawsuit Alleging Asthma Drug Caused Autism

Are You Looking for a High-Growth Dividend Stock?

NVS

Zacks

10 days ago

Are You Looking for a High-Growth Dividend Stock?

Judge shuts down drugmakers’ 340B rebate plans, for now

NVS

Healthcare Dive

13 days ago

Judge shuts down drugmakers’ 340B rebate plans, for now

Novartis (NVS) Upgraded to Buy: What Does It Mean for the Stock?

NVS

Zacks

16 days ago

Novartis (NVS) Upgraded to Buy: What Does It Mean for the Stock?

Should Value Investors Buy Novartis (NVS) Stock?

NVS

Zacks

17 days ago

Should Value Investors Buy Novartis (NVS) Stock?

New Novartis data at ASCO and EHA showcase momentum of pioneering portfolio with promising pipeline

NVS

GlobeNewswire

17 days ago

New Novartis data at ASCO and EHA showcase momentum of pioneering portfolio with promising pipeline

GSK Inks $2B Deal With Boston Pharmaceuticals to Buy Liver Disease Drug

NVS

Zacks

17 days ago

GSK Inks $2B Deal With Boston Pharmaceuticals to Buy Liver Disease Drug

NVS

MT Newswires

17 days ago

Incyte to Pay Novartis $280 Million to Resolve Jakafi Royalties Dispute

RHHBY to Invest $1.25B to Boost Manufacturing Footprint in US

NVS

Zacks

19 days ago

RHHBY to Invest $1.25B to Boost Manufacturing Footprint in US

Drugmakers Avoid Worst-Case Pricing Scenario for Now

NVS

The Wall Street Journal

19 days ago

Drugmakers Avoid Worst-Case Pricing Scenario for Now

NVS

Morningstar Research

19 days ago

Analyst Report: Novartis AG

NVS

MT Newswires

19 days ago

European Equities Close Higher in Monday Trading as US, China Truce Relieves Investors

NVS

MT Newswires

20 days ago

Sector Update: Health Care Stocks Advance Premarket Monday

NVS

MT Newswires

20 days ago

Sector Update: Health Care

NVS

MT Newswires

20 days ago

Market Chatter: Novartis to Continue Malaria Drug Production Despite Uncertain Demand

Trump’s Plan to Cut Drug Prices Hits Pfizer, Other Pharma Stocks

NVS

The Wall Street Journal

20 days ago

Trump’s Plan to Cut Drug Prices Hits Pfizer, Other Pharma Stocks

NVS

The Wall Street Journal

20 days ago

Trump's Plan to Cut Drug Prices Hits Pfizer, Other Pharma Stocks

Novartis to keep making malaria drugs if orders dry up amid aid cuts

NVS

Reuters

20 days ago

Novartis to keep making malaria drugs if orders dry up amid aid cuts

Here's Why Novartis (NVS) is a Strong Momentum Stock

NVS

Zacks

23 days ago

Here's Why Novartis (NVS) is a Strong Momentum Stock

NVS

Thomson Reuters StreetEvents

24 days ago

Q1 2025 Schrodinger Inc Earnings Call

Schrodinger Inc (SDGR) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ...

NVS

GuruFocus.com

24 days ago

Schrodinger Inc (SDGR) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ...

Novartis (NVS) is a Great Momentum Stock: Should You Buy?

NVS

Zacks

a month ago

Novartis (NVS) is a Great Momentum Stock: Should You Buy?

Why Novartis (NVS) is a Great Dividend Stock Right Now

NVS

Zacks

a month ago

Why Novartis (NVS) is a Great Dividend Stock Right Now

NVS

MT Newswires

a month ago

BioNTech Names Ramon Zapata-Gomez as Chief Financial Officer

Novartis to buy Regulus Therapeutics for as much as $1.7 billion

NVS

LA Times

a month ago

Novartis to buy Regulus Therapeutics for as much as $1.7 billion

Biotech Alert: Searches spiking for these stocks today

NVS

TipRanks

a month ago

Biotech Alert: Searches spiking for these stocks today

Novartis to strengthen renal disease portfolio with Regulus

NVS

Pharmaceutical Technology

a month ago

Novartis to strengthen renal disease portfolio with Regulus

NVS

MT Newswires

a month ago

Sector Update: Health Care Stocks Rise Wednesday Afternoon

NVS

MT Newswires

a month ago

Sector Update: Health Care

Why Novartis (NVS) is a Top Value Stock for the Long-Term

NVS

Zacks

a month ago

Why Novartis (NVS) is a Top Value Stock for the Long-Term

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

NVS

Zacks

a month ago

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Novartis to acquire Regulus in deal for kidney disease drug

NVS

BioPharma Dive

a month ago

Novartis to acquire Regulus in deal for kidney disease drug

Stocks to Watch Wednesday: Humana, Snap, Visa, Super Micro

NVS

The Wall Street Journal

a month ago

Stocks to Watch Wednesday: Humana, Snap, Visa, Super Micro

Novartis to Acquire Regulus in $1.7 Billion Deal

NVS

The Wall Street Journal

a month ago

Novartis to Acquire Regulus in $1.7 Billion Deal

NVS

MT Newswires

a month ago

Novartis to Acquire Regulus Therapeutics

NVS

GlobeNewswire

a month ago

Novartis to acquire Regulus Therapeutics and farabursen, an investigational microRNA inhibitor to treat ADPKD, the most common genetic cause of renal failure

Novartis AG (NVS) Q1 2025 Earnings Call Highlights: Impressive Growth and Strategic Advancements

NVS

GuruFocus.com

a month ago

Novartis AG (NVS) Q1 2025 Earnings Call Highlights: Impressive Growth and Strategic Advancements

NVS

Morningstar Research

a month ago

Analyst Report: Novartis AG

Novartis Scores A Beat-And-Raise Quarter — And Shares Make A Break For A Buy Point

NVS

Investor's Business Daily

a month ago

Novartis Scores A Beat-And-Raise Quarter — And Shares Make A Break For A Buy Point

Compared to Estimates, Novartis (NVS) Q1 Earnings: A Look at Key Metrics

NVS

Zacks

a month ago

Compared to Estimates, Novartis (NVS) Q1 Earnings: A Look at Key Metrics

Novartis Creeps Toward A Breakout On Its Beat-And-Raise

NVS

Investor's Business Daily

a month ago

Novartis Creeps Toward A Breakout On Its Beat-And-Raise

NVS

MT Newswires

a month ago

Novartis Q1 Core Earnings, Sales Rise; 2025 Outlook Set

NVS

Associated Press Finance

a month ago

Novartis: Q1 Earnings Snapshot

Novartis Lifts Guidance After Profit, Sales Top Views

NVS

The Wall Street Journal

a month ago

Novartis Lifts Guidance After Profit, Sales Top Views

Novartis continues strong momentum with double-digit sales growth, robust margin expansion and multiple approvals in Q1

NVS

GlobeNewswire

a month ago

Novartis continues strong momentum with double-digit sales growth, robust margin expansion and multiple approvals in Q1

Sandoz CEO slams EU-wide drug price proposal, warns US tariffs will hurt patient access

NVS

Reuters

a month ago

Sandoz CEO slams EU-wide drug price proposal, warns US tariffs will hurt patient access

These 2 Top Dividend Stocks Are Making Moves to Avoid the Impact of Tariffs: Are They Buys?

NVS

Motley Fool

a month ago

These 2 Top Dividend Stocks Are Making Moves to Avoid the Impact of Tariffs: Are They Buys?

NVS

MT Newswires

a month ago

Update: Novartis, Sanofi CEOs Say EU Should Hike Drug Prices to Boost Innovation

NVS

MT Newswires

a month ago

Novartis, Sanofi CEOs Say EU Should Hike Drug Prices to Boost Innovation

Why Novartis (NVS) is a Top Momentum Stock for the Long-Term

NVS

Zacks

a month ago

Why Novartis (NVS) is a Top Momentum Stock for the Long-Term

Incyte Gears Up to Report Q1 Earnings: Here's What You Should Know

NVS

Zacks

a month ago

Incyte Gears Up to Report Q1 Earnings: Here's What You Should Know

European pharma companies push for higher drug prices in EU amid U.S. tariff threats

NVS

Reuters

a month ago

European pharma companies push for higher drug prices in EU amid U.S. tariff threats

Novartis to Report Q1 Earnings: Will Key Drugs Maintain Momentum?

NVS

Zacks

a month ago

Novartis to Report Q1 Earnings: Will Key Drugs Maintain Momentum?

Why Novartis (NVS) is a Top Dividend Stock for Your Portfolio

NVS

Zacks

a month ago

Why Novartis (NVS) is a Top Dividend Stock for Your Portfolio

NVS

Zacks

a month ago

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

2 Dividend Stocks Defying the Tariff-Fueled Market Correction to Buy and Hold Forever

NVS

Motley Fool

a month ago

2 Dividend Stocks Defying the Tariff-Fueled Market Correction to Buy and Hold Forever

Novartis scores NFL deal to tackle health outcomes

NVS

Pharma Voice

a month ago

Novartis scores NFL deal to tackle health outcomes

NVS

MT Newswires

2 months ago

BNP Paribas Initiates Novartis at Outperform Rating, $116 Price Target

Novartis (NVS) Unleashes $23BN Strategic Investment Masterstroke

NVS

TipRanks

2 months ago

Novartis (NVS) Unleashes $23BN Strategic Investment Masterstroke

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

NVS

Zacks

2 months ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Novartis (NVS) Surges 4.0%: Is This an Indication of Further Gains?

NVS

Zacks

2 months ago

Novartis (NVS) Surges 4.0%: Is This an Indication of Further Gains?

NVS

Zacks

2 months ago

The Zacks Analyst Blog AbbVie's, Rinvoq and AstraZeneca's and Novartis

Novartis Commits $23 Billion to U.S. Expansion, Eyes Full Domestic Production of Key Medicines

NVS

GuruFocus.com

2 months ago

Novartis Commits $23 Billion to U.S. Expansion, Eyes Full Domestic Production of Key Medicines

NVS Plans to Invest $23B in US Manufacturing Sites Amid Tariff Threat

NVS

Zacks

2 months ago

NVS Plans to Invest $23B in US Manufacturing Sites Amid Tariff Threat

Novartis commits $23bn to US manufacturing amid tariff threats

NVS

Pharmaceutical Technology

2 months ago

Novartis commits $23bn to US manufacturing amid tariff threats

Pharma Stock Roundup: EU Nod to Expanded Use of ABBV, AZN Drugs & More

NVS

Zacks

2 months ago

Pharma Stock Roundup: EU Nod to Expanded Use of ABBV, AZN Drugs & More

Novartis Stock Rises After Swiss Drugmaker Promises to Boost U.S. Manufacturing

NVS

The Wall Street Journal

2 months ago

Novartis Stock Rises After Swiss Drugmaker Promises to Boost U.S. Manufacturing

NVS

MT Newswires

2 months ago

Sector Update: Health Care Stocks Mixed Premarket Friday

NVS

MT Newswires

2 months ago

Sector Update: Health Care

This Pharma Giant Will Invest $23 Billion in the U.S. It’s a Sign Trump’s Tariffs Are Working.

NVS

Barrons.com

2 months ago

This Pharma Giant Will Invest $23 Billion in the U.S. It’s a Sign Trump’s Tariffs Are Working.

Stocks to Watch Friday: JPMorgan, Wells Fargo, BlackRock, Novartis

NVS

The Wall Street Journal

2 months ago

Stocks to Watch Friday: JPMorgan, Wells Fargo, BlackRock, Novartis

Novartis Plans $23B Investment in US Facilities as Trump Threatens Pharma Tariffs

NVS

Investopedia

2 months ago

Novartis Plans $23B Investment in US Facilities as Trump Threatens Pharma Tariffs

Swiss Drugmaker Novartis Promises to Boost U.S. Manufacturing Amid Tariff Threats

NVS

The Wall Street Journal

2 months ago

Swiss Drugmaker Novartis Promises to Boost U.S. Manufacturing Amid Tariff Threats

Novartis to spend $23B to expand in the US

NVS

Yahoo Finance Video

2 months ago

Novartis to spend $23B to expand in the US

NVS

MT Newswires

2 months ago

Sector Update: Health Care Stocks Retreat Late Afternoon

Novo Nordisk, AbbVie, Other Stocks Tumble After Trump Threatens Pharma Tariffs

NVS

The Wall Street Journal

2 months ago

Novo Nordisk, AbbVie, Other Stocks Tumble After Trump Threatens Pharma Tariffs

NVS

Argus Research

2 months ago

Weekly Stock List

NVS

Argus Research

2 months ago

Market Digest: NVS

NVS

Argus Research

2 months ago

Analyst Report: Novartis AG

This Type of Cholesterol Is a Risk Factor for Heart Disease. Emerging Drugs from Lilly and Amgen Could Treat It.

NVS

Barrons.com

2 months ago

This Type of Cholesterol Is a Risk Factor for Heart Disease. Emerging Drugs from Lilly and Amgen Could Treat It.

Pharma Stock Roundup: FDA Nod to SNY, AZN & NVS, JNJ Talc Suits Failure

NVS

Zacks

2 months ago

Pharma Stock Roundup: FDA Nod to SNY, AZN & NVS, JNJ Talc Suits Failure

Trial monitors recommend Elevidys studies continue; Novartis kidney drug approved

NVS

BioPharma Dive

2 months ago

Trial monitors recommend Elevidys studies continue; Novartis kidney drug approved

Novartis Secures Third FDA Approval For Its Kidney Disease Portfolio In One Year

NVS

Benzinga

2 months ago

Novartis Secures Third FDA Approval For Its Kidney Disease Portfolio In One Year

FDA Grants Accelerated Approval to NVS Kidney Disease Drug

NVS

Zacks

2 months ago

FDA Grants Accelerated Approval to NVS Kidney Disease Drug

NVS

MT Newswires

2 months ago

Sector Update: Health Care Stocks Lean Lower Premarket Thursday

NVS

MT Newswires

2 months ago

Novartis Gets FDA Accelerated Approval for Vanrafia

Novartis receives FDA accelerated approval for Vanrafia® (atrasentan), the first and only selective endothelin A receptor antagonist for proteinuria reduction in primary IgA nephropathy (IgAN)

NVS

PR Newswire

2 months ago

Novartis receives FDA accelerated approval for Vanrafia® (atrasentan), the first and only selective endothelin A receptor antagonist for proteinuria reduction in primary IgA nephropathy (IgAN)

Big Pharma Avoids Worst-Case Tariff Scenario

NVS

The Wall Street Journal

2 months ago

Big Pharma Avoids Worst-Case Tariff Scenario

NVS

Zacks

2 months ago

Novartis (NVS) Could Be a Great Choice

APLS' Empaveli sNDA for 2 Rare Kidney Diseases Gets FDA Priority Tag

NVS

Zacks

2 months ago

APLS' Empaveli sNDA for 2 Rare Kidney Diseases Gets FDA Priority Tag

Leqembi’s EU review drags on; Sanofi gets a new development head

NVS

BioPharma Dive

2 months ago

Leqembi’s EU review drags on; Sanofi gets a new development head

Isomorphic raises $600M on big ambitions for AI drugmaking tech

NVS

BioPharma Dive

2 months ago

Isomorphic raises $600M on big ambitions for AI drugmaking tech

JNJ's Rybrevant-Lazcluze Combo Outshines AZN's Tagrisso in Lung Cancer

NVS

Zacks

2 months ago

JNJ's Rybrevant-Lazcluze Combo Outshines AZN's Tagrisso in Lung Cancer

Novartis appoints Karen Hale, Chief Legal and Compliance Officer, as Klaus Moosmayer, Chief Ethics, Risk & Compliance Officer, steps down from the Executive Committee of Novartis

NVS

GlobeNewswire

2 months ago

Novartis appoints Karen Hale, Chief Legal and Compliance Officer, as Klaus Moosmayer, Chief Ethics, Risk & Compliance Officer, steps down from the Executive Committee of Novartis

NVS

MT Newswires

2 months ago

Novartis Gets FDA Approval for Expanded Pluvicto Indication

FDA broadens use of Novartis’ radiopharma drug Pluvicto

NVS

BioPharma Dive

2 months ago

FDA broadens use of Novartis’ radiopharma drug Pluvicto

FDA approves Novartis radioligand therapy Pluvicto® for earlier use before chemotherapy in PSMA-positive metastatic castration-resistant prostate cancer

NVS

GlobeNewswire

2 months ago

FDA approves Novartis radioligand therapy Pluvicto® for earlier use before chemotherapy in PSMA-positive metastatic castration-resistant prostate cancer

Latest Novartis AG (NVS) News on June 1, 2025

Share on Social Networks: